Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy

NCT02129985 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Exenatide
DRUG: Metformin

Sponsor

xiaolong zhao

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]